Business Context and Reporting Period
Company: Zimmer Holdings, Inc. (Note: Filing name differs from request metadata "Zimmer Biomet Holdings, Inc.")
Filing Type: Form 8-K
Date of Report: July 26, 2006
Reporting Period: Quarter ended June 30, 2006
This filing reports the results of operations for the quarter ended June 30, 2006. The detailed financial data is contained in the attached Press Release (Exhibit 99.1), which is incorporated by reference.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached Exhibit 99.1.
The company reports the following non-GAAP financial measures in the referenced press release:
- Adjusted net earnings and adjusted diluted EPS (excluding acquisition/integration expenses and inventory step-up).
- Adjusted net margin, adjusted operating margin, and adjusted gross margin.
- Constant currency sales (excluding foreign currency exchange rate effects).
Results also reflect the adoption of SFAS 123(R) regarding share-based payments. The company provides reconciliations of these non-GAAP measures to GAAP measures in the press release.
Material Changes and Accounting Adjustments
The filing highlights several factors affecting comparability with prior periods:
- Acquisitions: Results include the impact of prior acquisitions of Centerpulse AG (2003) and Implex Corp. (2004).
- Accounting Standard Change: Financial results include share-based payment expenses resulting from the adoption of SFAS 123(R). The company presents adjusted measures excluding this effect to facilitate comparison with prior periods.
- Currency: Constant currency sales are reported to isolate organic growth from foreign exchange fluctuations.
Guidance, Outlook, and Risks
The filing text does not contain specific forward-looking guidance, outlook figures, or a detailed risk factor section. It notes that the information is furnished pursuant to Item 2.02 and is not deemed "filed" with the SEC for incorporation by reference into other filings. Management states that non-GAAP measures should be considered in addition to, not as a substitute for, GAAP measures.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP financial figures (revenue, EPS, margins).
- Verify the reconciliation between non-GAAP adjusted measures and GAAP measures provided in the press release.
- Assess the specific impact of SFAS 123(R) share-based payments on net earnings.
- Confirm the constant currency exchange rates used to calculate sales growth.
- Check for any updates on integration expenses related to the Centerpulse AG and Implex Corp. acquisitions.